
### [MONDO:0020087](http://purl.obolibrary.org/obo/MONDO_0020087)
**Label:** genetic lipodystrophy

**Subclasses:** [MONDO:0019555](http://purl.obolibrary.org/obo/MONDO_0019555) (panniculitis and localized lipodystrophy), [MONDO:0016584](http://purl.obolibrary.org/obo/MONDO_0016584) (mandibuloacral dysplasia), [MONDO:0019556](http://purl.obolibrary.org/obo/MONDO_0019556) (pressure-induced localized lipoatrophy), [MONDO:0019553](http://purl.obolibrary.org/obo/MONDO_0019553) (drug-induced localized lipodystrophy), [MONDO:0010020](http://purl.obolibrary.org/obo/MONDO_0010020) (congenital generalized lipodystrophy type 2), [MONDO:0018883](http://purl.obolibrary.org/obo/MONDO_0018883) (Berardinelli-Seip congenital lipodystrophy), [MONDO:0013572](http://purl.obolibrary.org/obo/MONDO_0013572) (Keppen-Lubinsky syndrome), [MONDO:0019554](http://purl.obolibrary.org/obo/MONDO_0019554) (idiopathic localized lipodystrophy), [MONDO:0009312](http://purl.obolibrary.org/obo/MONDO_0009312) (lipodystrophy due to peptidic growth factors deficiency), [MONDO:0020089](http://purl.obolibrary.org/obo/MONDO_0020089) (acquired lipodystrophy), [MONDO:0019552](http://purl.obolibrary.org/obo/MONDO_0019552) (centrifugal lipodystrophy), [MONDO:0007906](http://purl.obolibrary.org/obo/MONDO_0007906) (familial partial lipodystrophy, Dunnigan type), [MONDO:0015493](http://purl.obolibrary.org/obo/MONDO_0015493) (lipoatrophy with diabetes, leukomelanodermic papules, liver steatosis, and hypertrophic cardiomyopathy), [MONDO:0009557](http://purl.obolibrary.org/obo/MONDO_0009557) (mandibuloacral dysplasia with type A lipodystrophy), [MONDO:0017230](http://purl.obolibrary.org/obo/MONDO_0017230) (autosomal semi-dominant severe lipodystrophic laminopathy), [MONDO:0009910](http://purl.obolibrary.org/obo/MONDO_0009910) (Wiedemann-Rautenstrauch syndrome), [MONDO:0019193](http://purl.obolibrary.org/obo/MONDO_0019193) (acquired generalized lipodystrophy), [MONDO:0019194](http://purl.obolibrary.org/obo/MONDO_0019194) (localized lipodystrophy), [MONDO:0020088](http://purl.obolibrary.org/obo/MONDO_0020088) (familial partial lipodystrophy), [MONDO:0010026](http://purl.obolibrary.org/obo/MONDO_0010026) (short syndrome), [MONDO:0012104](http://purl.obolibrary.org/obo/MONDO_0012104) (partial acquired lipodystrophy), [MONDO:0013478](http://purl.obolibrary.org/obo/MONDO_0013478) (PLIN1-related familial partial lipodystrophy), [MONDO:0014402](http://purl.obolibrary.org/obo/MONDO_0014402) (severe neurodegenerative syndrome with lipodystrophy), [MONDO:0012923](http://purl.obolibrary.org/obo/MONDO_0012923) (congenital generalized lipodystrophy type 3), [MONDO:0011976](http://purl.obolibrary.org/obo/MONDO_0011976) (lipodystrophy-intellectual disability-deafness syndrome), [MONDO:0014431](http://purl.obolibrary.org/obo/MONDO_0014431) (LIPE-related familial partial lipodystrophy), [MONDO:0012074](http://purl.obolibrary.org/obo/MONDO_0012074) (mandibuloacral dysplasia with type B lipodystrophy), [MONDO:0014098](http://purl.obolibrary.org/obo/MONDO_0014098) (CIDEC-related familial partial lipodystrophy), [MONDO:0012072](http://purl.obolibrary.org/obo/MONDO_0012072) (familial partial lipodystrophy, KC6bberling type), [MONDO:0012071](http://purl.obolibrary.org/obo/MONDO_0012071) (congenital generalized lipodystrophy type 1), [MONDO:0019192](http://purl.obolibrary.org/obo/MONDO_0019192) (AKT2-related familial partial lipodystrophy), [MONDO:0013225](http://purl.obolibrary.org/obo/MONDO_0013225) (congenital generalized lipodystrophy type 4), [MONDO:0011448](http://purl.obolibrary.org/obo/MONDO_0011448) (PPARG-related familial partial lipodystrophy), 

**Mapped go classes:** [GO:0007094](http://purl.obolibrary.org/obo/GO_0007094) (mitotic spindle assembly checkpoint), [GO:0019915](http://purl.obolibrary.org/obo/GO_0019915) (lipid storage), [GO:0005198](http://purl.obolibrary.org/obo/GO_0005198) (structural molecule activity), [GO:0046854](http://purl.obolibrary.org/obo/GO_0046854) (phosphatidylinositol phosphorylation), [GO:0042134](http://purl.obolibrary.org/obo/GO_0042134) (rRNA primary transcript binding), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0003841](http://purl.obolibrary.org/obo/GO_0003841) (1-acylglycerol-3-phosphate O-acyltransferase activity), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0046340](http://purl.obolibrary.org/obo/GO_0046340) (diacylglycerol catabolic process), [GO:0005901](http://purl.obolibrary.org/obo/GO_0005901) (caveola), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0048884](http://purl.obolibrary.org/obo/GO_0048884) (neuromast development), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0050790](http://purl.obolibrary.org/obo/GO_0050790) (regulation of catalytic activity), [GO:0070328](http://purl.obolibrary.org/obo/GO_0070328) (triglyceride homeostasis), [GO:0016411](http://purl.obolibrary.org/obo/GO_0016411) (acylglycerol O-acyltransferase activity), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0019888](http://purl.obolibrary.org/obo/GO_0019888) (protein phosphatase regulator activity), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0031072](http://purl.obolibrary.org/obo/GO_0031072) (heat shock protein binding), [GO:0070836](http://purl.obolibrary.org/obo/GO_0070836) (caveola assembly), [GO:0090342](http://purl.obolibrary.org/obo/GO_0090342) (regulation of cell aging), [GO:0005242](http://purl.obolibrary.org/obo/GO_0005242) (inward rectifier potassium channel activity), [GO:0005244](http://purl.obolibrary.org/obo/GO_0005244) (voltage-gated ion channel activity), [GO:0005882](http://purl.obolibrary.org/obo/GO_0005882) (intermediate filament), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0008237](http://purl.obolibrary.org/obo/GO_0008237) (metallopeptidase activity), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005637](http://purl.obolibrary.org/obo/GO_0005637) (nuclear inner membrane), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0017171](http://purl.obolibrary.org/obo/GO_0017171) (serine hydrolase activity), [GO:0005638](http://purl.obolibrary.org/obo/GO_0005638) (lamin filament), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0046474](http://purl.obolibrary.org/obo/GO_0046474) (glycerophospholipid biosynthetic process), [GO:0019236](http://purl.obolibrary.org/obo/GO_0019236) (response to pheromone), [GO:0016485](http://purl.obolibrary.org/obo/GO_0016485) (protein processing), [GO:0050688](http://purl.obolibrary.org/obo/GO_0050688) (regulation of defense response to virus), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0008286](http://purl.obolibrary.org/obo/GO_0008286) (insulin receptor signaling pathway), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0097194](http://purl.obolibrary.org/obo/GO_0097194) (execution phase of apoptosis), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0006813](http://purl.obolibrary.org/obo/GO_0006813) (potassium ion transport), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0000164](http://purl.obolibrary.org/obo/GO_0000164) (protein phosphatase type 1 complex), [GO:0009408](http://purl.obolibrary.org/obo/GO_0009408) (response to heat), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0071432](http://purl.obolibrary.org/obo/GO_0071432) (peptide mating pheromone maturation involved in conjugation with cellular fusion), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0033878](http://purl.obolibrary.org/obo/GO_0033878) (hormone-sensitive lipase activity), [GO:0035014](http://purl.obolibrary.org/obo/GO_0035014) (phosphatidylinositol 3-kinase regulator activity), [GO:0009303](http://purl.obolibrary.org/obo/GO_0009303) (rRNA transcription), [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005978](http://purl.obolibrary.org/obo/GO_0005978) (glycogen biosynthetic process), [GO:0005977](http://purl.obolibrary.org/obo/GO_0005977) (glycogen metabolic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005979](http://purl.obolibrary.org/obo/GO_0005979) (regulation of glycogen biosynthetic process), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0004806](http://purl.obolibrary.org/obo/GO_0004806) (triglyceride lipase activity), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0001819](http://purl.obolibrary.org/obo/GO_0001819) (positive regulation of cytokine production), [GO:2000147](http://purl.obolibrary.org/obo/GO_2000147) (positive regulation of cell motility), [GO:0060047](http://purl.obolibrary.org/obo/GO_0060047) (heart contraction), [GO:0006361](http://purl.obolibrary.org/obo/GO_0006361) (transcription initiation from RNA polymerase I promoter), [GO:0032809](http://purl.obolibrary.org/obo/GO_0032809) (neuronal cell body membrane), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0006363](http://purl.obolibrary.org/obo/GO_0006363) (termination of RNA polymerase I transcription), [GO:0045444](http://purl.obolibrary.org/obo/GO_0045444) (fat cell differentiation), [GO:0046935](http://purl.obolibrary.org/obo/GO_0046935) (1-phosphatidylinositol-3-kinase regulator activity), [GO:0004222](http://purl.obolibrary.org/obo/GO_0004222) (metalloendopeptidase activity), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0005942](http://purl.obolibrary.org/obo/GO_0005942) (phosphatidylinositol 3-kinase complex), [GO:0006998](http://purl.obolibrary.org/obo/GO_0006998) (nuclear envelope organization), [GO:0051321](http://purl.obolibrary.org/obo/GO_0051321) (meiotic cell cycle), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0034389](http://purl.obolibrary.org/obo/GO_0034389) (lipid particle organization), [GO:0016298](http://purl.obolibrary.org/obo/GO_0016298) (lipase activity), [GO:0019843](http://purl.obolibrary.org/obo/GO_0019843) (rRNA binding), [GO:0050995](http://purl.obolibrary.org/obo/GO_0050995) (negative regulation of lipid catabolic process), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0060036](http://purl.obolibrary.org/obo/GO_0060036) (notochord cell vacuolation), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0043551](http://purl.obolibrary.org/obo/GO_0043551) (regulation of phosphatidylinositol 3-kinase activity), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation), [GO:0006654](http://purl.obolibrary.org/obo/GO_0006654) (phosphatidic acid biosynthetic process), [GO:0008307](http://purl.obolibrary.org/obo/GO_0008307) (structural constituent of muscle), [GO:0001756](http://purl.obolibrary.org/obo/GO_0001756) (somitogenesis), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0030176](http://purl.obolibrary.org/obo/GO_0030176) (integral component of endoplasmic reticulum membrane), [GO:0010107](http://purl.obolibrary.org/obo/GO_0010107) (potassium ion import), [GO:0030299](http://purl.obolibrary.org/obo/GO_0030299) (intestinal cholesterol absorption), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0016788](http://purl.obolibrary.org/obo/GO_0016788) (hydrolase activity, acting on ester bonds), [GO:0042758](http://purl.obolibrary.org/obo/GO_0042758) (long-chain fatty acid catabolic process), [GO:0034098](http://purl.obolibrary.org/obo/GO_0034098) (VCP-NPL4-UFD1 AAA ATPase complex), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0030327](http://purl.obolibrary.org/obo/GO_0030327) (prenylated protein catabolic process), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0047372](http://purl.obolibrary.org/obo/GO_0047372) (acylglycerol lipase activity), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0001965](http://purl.obolibrary.org/obo/GO_0001965) (G-protein alpha-subunit binding), [GO:0034765](http://purl.obolibrary.org/obo/GO_0034765) (regulation of ion transmembrane transport), [GO:0015467](http://purl.obolibrary.org/obo/GO_0015467) (G-protein activated inward rectifier potassium channel activity), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0061026](http://purl.obolibrary.org/obo/GO_0061026) (cardiac muscle tissue regeneration), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:0060338](http://purl.obolibrary.org/obo/GO_0060338) (regulation of type I interferon-mediated signaling pathway), [GO:0008654](http://purl.obolibrary.org/obo/GO_0008654) (phospholipid biosynthetic process), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0006353](http://purl.obolibrary.org/obo/GO_0006353) (DNA-templated transcription, termination), [GO:0042403](http://purl.obolibrary.org/obo/GO_0042403) (thyroid hormone metabolic process), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0005811](http://purl.obolibrary.org/obo/GO_0005811) (lipid droplet), [GO:0004722](http://purl.obolibrary.org/obo/GO_0004722) (protein serine/threonine phosphatase activity), [GO:0071586](http://purl.obolibrary.org/obo/GO_0071586) (CAAX-box protein processing), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0016024](http://purl.obolibrary.org/obo/GO_0016024) (CDP-diacylglycerol biosynthetic process), [GO:0016303](http://purl.obolibrary.org/obo/GO_0016303) (1-phosphatidylinositol-3-kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 54.34%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.09%
- [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion) 51.09%
- [GO:0005638](http://purl.obolibrary.org/obo/GO_0005638) (lamin filament) 51.09%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 51.09%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.44%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) 36.44%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 36.44%
- [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) and [GO:0070161](http://purl.obolibrary.org/obo/GO_0070161) (anchoring junction) 36.44%
- [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction) and [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) 36.44%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 36.44%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 36.44%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 36.44%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 36.44%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 36.44%


